Combination therapy comprising antidiabetic and anticonvulsant agent

Details for Australian Patent Application No. 2002253838 (hide)

Owner Ortho-McNeil Pharmaceutical, Inc.

Inventors Connor, Gregory, S.

Agent Shelston IP

Pub. Number AU-B-2002253838

PCT Pub. Number WO2002/064210

Priority 60/244,225 30.10.00 US

Filing date 25 October 2001

Wipo publication date 28 August 2002

Acceptance publication date 9 November 2006

International Classifications

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002253838

9 November 2006 Application Accepted

  Published as AU-B-2002253838

8 March 2007 Standard Patent Sealed

21 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002253839-CIRCUIT FOR COUPLING ENERGY TO A PULSE FORMING NETWORK OR CAPACITOR

2002253837-CONTROLLED DISTRIBUTION TERMINAL BLOCK